{"log_id": 6253796374218869198, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 4.6e-05, "average": 0.997336, "min": 0.96885}, "location": {"width": 814, "top": 176, "height": 48, "left": 237}, "words": "静脉给药的)和非严重感染的发生率相当。最常见的非严重感染是上呼吸道感染"}, {"probability": {"variance": 0.000831, "average": 0.99389, "min": 0.823672}, "location": {"width": 823, "top": 223, "height": 52, "left": 237}, "words": "本品治疗达48个月的类风湿关节炎患者中出现严重感染的比例为6.3%,包括脓"}, {"probability": {"variance": 1e-06, "average": 0.999479, "min": 0.99519}, "location": {"width": 823, "top": 272, "height": 52, "left": 235}, "words": "肿(各种部位)、菌血症、支气管炎、滑囊炎、蜂窝组织炎、胆囊炎、腹泻、憩"}, {"probability": {"variance": 0.000133, "average": 0.99675, "min": 0.930977}, "location": {"width": 803, "top": 322, "height": 51, "left": 234}, "words": "室炎、心内膜炎(疑似)、胃肠炎、乙型肝炎、带状疱疹、腿部溃疡、口腔感染"}, {"probability": {"variance": 0.001391, "average": 0.993218, "min": 0.778965}, "location": {"width": 811, "top": 370, "height": 51, "left": 231}, "words": "骨髓炎、耳炎、腹膜炎、肺炎、肾盂肾炎、脓毒血症、脓毒性关节炎、鼻窦炎"}, {"probability": {"variance": 6e-06, "average": 0.998691, "min": 0.988411}, "location": {"width": 824, "top": 420, "height": 48, "left": 231}, "words": "皮肤感染、皮肤溃疡、尿道感染、血管炎以及伤口感染等。在为期2年的活性对"}, {"probability": {"variance": 1.2e-05, "average": 0.997719, "min": 0.981909}, "location": {"width": 823, "top": 466, "height": 50, "left": 229}, "words": "照试验中分别给予受试者本品、甲氨蝶呤或本品与甲氨蝶呤联用,三个治疗组发"}, {"probability": {"variance": 1.7e-05, "average": 0.998517, "min": 0.976924}, "location": {"width": 823, "top": 512, "height": 52, "left": 227}, "words": "生严重感染的发生率相似,但不能排除本品与甲氨蝶呤联用与感染发生率的增加"}, {"probability": {"variance": 0, "average": 0.999665, "min": 0.999627}, "location": {"width": 53, "top": 561, "height": 28, "left": 225}, "words": "有关"}, {"probability": {"variance": 0.001794, "average": 0.989486, "min": 0.760509}, "location": {"width": 778, "top": 611, "height": 51, "left": 271}, "words": "在斑块型银屑病患者中进行的24周安慰剂对照试验中品治疗组与安慰"}, {"probability": {"variance": 0.000425, "average": 0.99273, "min": 0.888565}, "location": {"width": 814, "top": 652, "height": 60, "left": 221}, "words": "剂治疗组的感染发生率相似。本品治疗组患者出现的严重感染包括:蜂窝组织炎"}, {"probability": {"variance": 0.022402, "average": 0.950127, "min": 0.359455}, "location": {"width": 811, "top": 701, "height": 56, "left": 221}, "words": "胃肠炎、肺炎、胆囊炎、骨髓炎、胃炎、阑尾炎链球菌导致的筋膜炎、炎"}, {"probability": {"variance": 6.1e-05, "average": 0.995706, "min": 0.963976}, "location": {"width": 813, "top": 748, "height": 57, "left": 216}, "words": "脓毒血症性休克、憩室炎、以及脓肿。在双盲放标签的银屑病关节炎试验中"}, {"probability": {"variance": 1e-06, "average": 0.999164, "min": 0.995594}, "location": {"width": 330, "top": 799, "height": 37, "left": 214}, "words": "1例患者报告严重感染(肺炎)"}, {"probability": {"variance": 0.01186, "average": 0.978215, "min": 0.372827}, "location": {"width": 852, "top": 842, "height": 58, "left": 263}, "words": "曾有使用本品发生严重和致命感染的报,报告的病原包括细菌分枝杆菌"}, {"probability": {"variance": 0.027725, "average": 0.925744, "min": 0.392493}, "location": {"width": 895, "top": 871, "height": 82, "left": 218}, "words": "(含结核病、病毒和真菌。病例发生于开始使用本品治疗后的数周性"}, {"probability": {"variance": 0.014886, "average": 0.95946, "min": 0.440245}, "location": {"width": 830, "top": 937, "height": 63, "left": 211}, "words": "些患者除了类风湿关节炎之外还有基础疾病(糖尿病、充血性心力衰竭、活动"}, {"probability": {"variance": 0.002432, "average": 0.981798, "min": 0.821183}, "location": {"width": 827, "top": 984, "height": 63, "left": 209}, "words": "性或慢性感染)(参见“注事项”)。一项临床试验表明,本品治疗可能增加患"}, {"probability": {"variance": 0.024857, "average": 0.942324, "min": 0.470341}, "location": {"width": 273, "top": 1035, "height": 41, "left": 209}, "words": "有脓毒血症患者的死率"}, {"probability": {"variance": 0.007607, "average": 0.9803, "min": 0.496566}, "location": {"width": 780, "top": 1084, "height": 52, "left": 257}, "words": "曾有机会致病菌感染的报告,包括侵袭性真菌感染、寄生虫(包括原虫)感"}, {"probability": {"variance": 0.001607, "average": 0.989616, "min": 0.76794}, "location": {"width": 814, "top": 1128, "height": 57, "left": 205}, "words": "染、细菌感染飞括利斯塔氏菌属和军团病杆菌属)以及非典型分枝杆菌感染"}, {"probability": {"variance": 1.2e-05, "average": 0.998464, "min": 0.980209}, "location": {"width": 827, "top": 1180, "height": 51, "left": 204}, "words": "在一项综合的临床试验数据中,15402名本品治疗患者出现机会致病菌感染的总"}, {"probability": {"variance": 0.000476, "average": 0.992629, "min": 0.898611}, "location": {"width": 817, "top": 1228, "height": 49, "left": 203}, "words": "体发生率为0.09%调整后暴露率是每100个患者年中发生0.06个事件。上市后"}, {"probability": {"variance": 7e-06, "average": 0.999198, "min": 0.984077}, "location": {"width": 827, "top": 1275, "height": 51, "left": 203}, "words": "全球范围内出现机会致病菌感染的病例中约有一半为侵袭性真菌感染。最常报告"}, {"probability": {"variance": 6e-06, "average": 0.999233, "min": 0.985945}, "location": {"width": 829, "top": 1323, "height": 50, "left": 200}, "words": "的侵袭性真菌感染为肺囊虫属和曲霉菌属。侵袭性真菌感染导致了一半以上机会"}, {"probability": {"variance": 2e-06, "average": 0.999035, "min": 0.993088}, "location": {"width": 830, "top": 1370, "height": 50, "left": 198}, "words": "致病菌感染患者的死亡。主要的致命性结果出现在肺孢子虫性肺炎、未确定的系"}, {"probability": {"variance": 3.5e-05, "average": 0.997387, "min": 0.975321}, "location": {"width": 605, "top": 1418, "height": 44, "left": 197}, "words": "统性真菌感染以及曲霉菌病的患者中(参见“注意事项”)"}, {"probability": {"variance": 0, "average": 0.999793, "min": 0.99944}, "location": {"width": 101, "top": 1468, "height": 30, "left": 198}, "words": "自身抗体"}, {"probability": {"variance": 0.000242, "average": 0.996167, "min": 0.908451}, "location": {"width": 779, "top": 1515, "height": 49, "left": 244}, "words": "在多个时间点对患者的血清样本进行自身抗体检测。本品治疗组类风湿关节"}], "language": 3}